The Prothrombin Factor II G20210A Mutation with Pulmonary Thromboembolism and a Normal Level of Fibrin Degradation Products
Main Authors: | Nagorni-Obradovic Lj, Miljic P, Djordjevic V, Pešut D, Jovanovic D, Stojsic J, Stevic R, Radojkovic D |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2009-01-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/v10034-010-0007-7 |
Similar Items
-
Homozygous Carrier of Prothrombin G20210A Mutation with Massive Pulmonary Embolism and His Family: Gender Differences of Susceptibility to Mutation
by: Stoeva Natalia Y., et al.
Published: (2016-03-01) -
Prothrombin G20210A Mutation is not a Risk Factor for Pediatric Acute Lymphoblastic Leukemia in Western Iran
by: Zohreh Rahimi, et al.
Published: (2013-10-01) -
Epidemiology of prothrombin G20210A polymorphism in the Southern Iran
by: Mohadeseh Arabnejad, et al.
Published: (2015-08-01) -
Frequency of factor V Leiden (G1691A) and prothrombin (G20210A) polymorphisms in Population of Kerman Province, Iran
by: Nasrollah Saleh-gohari, et al.
Published: (2017-09-01) -
Prothrombin G20210A and Factor V Leiden mutations in ischemic arterial stroke
by: Hafize Nalan Güneş
Published: (2018-04-01)